News
Wall Street Analysts See a 76.42% Upside in Celldex (CLDX): Can the Stock Really Move This High?
Shares of Celldex Therapeutics (CLDX) have gained 4% over the past four weeks to close the last trading session at $32.31, but there could still be a solid upside left in the stock if short-term
Does Crescent Energy (CRGY) Have the Potential to Rally 26.3% as Wall Street Analysts Expect?
Crescent Energy (CRGY) closed the last trading session at $13.46, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 25.8% Upside in First American Financial (FAF): Can the Stock Really Move This High?
Shares of First American Financial (FAF) have gained 17.7% over the past four weeks to close the last trading session at $68.52, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe Tetra (TTEK) Could Rally 30.5%: Here's is How to Trade
Tetra Tech (TTEK) closed the last trading session at $31.67, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Predict a 27.72% Upside in Amphenol (APH): Here's What You Should Know
Shares of Amphenol (APH) have gained 11.2% over the past four weeks to close the last trading session at $142.3, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Believe Gloo Holdings, Inc. (GLOO) Could Rally 96.3%: Here's is How to Trade
Gloo Holdings, Inc. (GLOO) closed the last trading session at $7.03, gaining 31.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
Vericel Corporation (VCEL) closed the last trading session at $35.57, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Should You Buy Opera Limited Sponsored ADR (OPRA) After Golden Cross?
Opera Limited Sponsored ADR (OPRA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OPRA's 50-day simple moving average
Cardinal (CAH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in Cardinal Health (CAH) lately. While the stock has lost 8.8% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in its
Wall Street Analysts See a 31.35% Upside in Ultra Clean (UCTT): Can the Stock Really Move This High?
Shares of Ultra Clean Holdings (UCTT) have gained 18.1% over the past four weeks to close the last trading session at $74.61, but there could still be a solid upside left in the stock if short-term
PubMatic, Inc. (PUBM) Now Trades Above Golden Cross: Time to Buy?
PubMatic, Inc. (PUBM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PUBM's 50-day simple moving average crossed above its
Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet
Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $31.83, gaining 14.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 41.19% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Shares of Omnicell (OMCL) have gained 25.3% over the past four weeks to close the last trading session at $42.8, but there could still be a solid upside left in the stock if short-term price targets
First Hawaiian (FHB) Just Flashed Golden Cross Signal: Do You Buy?
After reaching an important support level, First Hawaiian, Inc. (FHB) could be a good stock pick from a technical perspective. FHB recently experienced a "golden cross" event, which saw its 50-day
3 Defense Stocks Poised to Surpass Q1 Earnings Expectations
The Zacks Aerospace sector’s first-quarter 2026 earnings are expected to outperform, driven by heightened order activity amid rising geopolitical tensions. A substantial backlog is providing clear
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
The first-quarter 2026 reporting cycle of the Medical sector is in full swing. The sector primarily comprises pharma/biotech and medical device companies.
Many pharma giants, like AbbVie and Eli
Why Landstar System (LSTR) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Signet (SIG) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Here's Why Roku (ROKU) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Why Altria (MO) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Avnet (AVT) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Kennametal (KMT) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Jones Lang LaSalle (JLL) is a Top-Ranked Momentum Stock: Should You Buy?
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Incyte (INCY) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Here's Why General Motors (GM) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different